Levetiracetam
Product Images NDC 42254-310
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 42254-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Responder Rate (≥50% Reduction From Baseline) In Study 1 (41a781b4 Da67 4650 A99b 593fc34465da 02)
Figure 2. Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (41a781b4 Da67 4650 A99b 593fc34465da 03)
Figure 3. Responder Rate (≥50% Reduction From Baseline) In Study 3 (41a781b4 Da67 4650 A99b 593fc34465da 04)
Figure 4. Responder Rate (≥50% Reduction From Baseline) (41a781b4 Da67 4650 A99b 593fc34465da 05)
Levetiracetam 250mg (41a781b4 Da67 4650 A99b 593fc34465da 06)
This is a description of a medication called Levetiracetam 250mg tablets from the pharmaceutical company Lupin Limited. The product ID is QL031060 and the tablets come in a bottle of 460. The tablets are film-coated and have the letters "L" and "ax" imprinted on them. The medication should be stored at a controlled room temperature. No other information about the medication usage or side effects is given.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.